Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
NPJ Breast Cancer|November 4, 2025
Targeting GD2 with naxitamab overcomes GD3 synthase-driven immune suppression in triple-negative breast cancerVivek Anand, Bolutyfe Oderinde, Maryam Siddiqui, et al.Journal of Cellular and Molecular Medicine|January 11, 2025
FT538, iPSC-derived NK cells, enhance AML cell killing when combined with chemotherapyAmanda Eckstrom, Anudishi Tyagi, Sajid Mahmood, et al.Blood|March 1, 2022
Evidence supporting a role for the immune checkpoint protein B7-H3 in NK cell-mediated cytotoxicity against AMLAnudishi Tyagi, Stanley Ly, Fouad El-Dana, et al.Oncogene|May 17, 2025
GD3 synthase drives resistance to p53-induced apoptosis in breast cancer by modulating mitochondrial functionVivek Anand, Fouad El-Dana, Natalia Baran, et al.Molecular Cancer Therapeutics|September 22, 2018
ST8SIA1 Regulates Tumor Growth and Metastasis in TNBC by Activating the FAK-AKT-mTOR Signaling PathwayKhoa Nguyen, Yuanqing Yan, Bin Yuan, et al.Blood|June 7, 2013
Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftmentV Lokesh Battula, Ye Chen, Maria da Graca Cabreira, et al.British Journal of Cancer|November 23, 2021
Metabolic stress induces GD2+ cancer stem cell-like phenotype in triple-negative breast cancerAppalaraju Jaggupilli, Stanley Ly, Khoa Nguyen, et al.Haematologica|March 17, 2018
Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survivalSteven M Kornblau, Peter P Ruvolo, Rui-Yu Wang, et al.Leukemia|November 25, 2023
TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclaxAnudishi Tyagi, Appalaraju Jaggupilli, Stanley Ly, et al.JCI Insight|July 7, 2017
AML-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growthV Lokesh Battula, Phuong M Le, Jeffrey C Sun, et al.Pageof 2